Strong momentum in Project Nanoenzalutamide
Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m.…
Annual Review 2023. Financial Statements for financial year 2023
To the report To the webcast
Invitation to Nanoform’s Q4 and FY 2023 Report Presentation
Press release Nanoform Finland Plc February 16, 2024 11:00 a.m.…
Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines
Inside information Nanoform Finland Plc February 15, 2024 12:45 Finnish…
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
Inside information Nanoform Finland Plc January 26th, 2024 11:20 Finnish…
Nanoform Finland Plc – Manager’s transactions – Albert Hæggström
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – David Rowe
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Nanoform Finland Plc – Manager’s transactions – Edward Hæggström
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…